Turicibacter sanguinis
Selected indexed studies
- Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut. (Nat Microbiol, 2019) [PMID:31477894]
- Turicibacter sanguinis is a candidate gut microbial pathobiont that promotes metabolic dysfunction-associated steatohepatitis. (mSystems, 2026) [PMID:42148776]
- Bloodstream co-infection with Turicibacter sanguinis and Desulfovibrio desulfuricans in a patient with a flare of ulcerative colitis - A case report and review of the literature. (IDCases, 2024) [PMID:39309042]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut. (2019) pubmed
- Turicibacter sanguinis is a candidate gut microbial pathobiont that promotes metabolic dysfunction-associated steatohepatitis. (2026) pubmed
- Bloodstream co-infection with Turicibacter sanguinis and Desulfovibrio desulfuricans in a patient with a flare of ulcerative colitis - A case report and review of the literature. (2024) pubmed
- Complete Genome Sequence and Annotation for Turicibacter sanguinis MOL361(T) (DSM 14220). (2020) pubmed
- Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium. (2002) pubmed
- Multiomics Analysis Reveals Leucine Deprivation Promotes Bile Acid Synthesis by Upregulating Hepatic CYP7A1 and Intestinal Turicibacter sanguinis in Mice. (2024) pubmed
- Draft genome sequence of Turicibacter sanguinis PC909, isolated from human feces. (2011) pubmed
- Turicibacter faecis sp. nov., isolated from faeces of heart failure mouse model. (2024) pubmed
- Turicibacter bilis sp. nov., a novel bacterium isolated from the chicken eggshell and swine ileum. (2022) pubmed
- The ecology of the microbiota in children with obesity is associated with the intake of carbohydrates and insulin resistance. (2025) pubmed